🇺🇸
United States · US · US:73292-011_0e3b8e29-64dd-430f-998d-5aca82258a8d
Viltepso
Orange BookUNIISPLATC M09AX12
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerNS Pharma, Inc.
CountryUS (United States)
ATC codeM09AX12
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1173292011011 VIAL, GLASS in 1 CARTON (73292-011-01) / 1 INJECTION, SOLUTION in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
SXA7YP6EKX
VILTOLARSEN
RxCUI 2389840
Orange Book
N212154
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "SXA7YP6EKX",
"rxcui": "2389840",
"inchikey": null,
"display_name": "VILTOLARSEN",
"substance_type": "nucleicAcid",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123": {
"match": "brand_token",
"title": "VILTEPSO (VILTOLARSEN) INJECTION, SOLUTION [NS PHARMA, INC.]",
"spl_version": "7",
"published_date": "2025-07-21"
}
},
"productid": "73292-011_0e3b8e29-64dd-430f-998d-5aca82258a8d",
"productndc": "73292-011",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "212154",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "250MG/5ML (50MG/ML)",
"product_no": "001",
"approval_date": "Aug 12, 2020"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "VILTOLARSEN",
"proprietary_name": "Viltepso",
"active_ingred_unit": "mg/1",
"application_number": "NDA212154",
"marketing_category": "NDA",
"nonproprietary_name": "viltolarsen",
"start_marketing_date": "20200813",
"active_numerator_strength": "250"
}Access this data programmatically
Query Viltepso and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.